{"name":"AN2 Therapeutics, Inc","slug":"an2-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":24769000,"netIncome":-35174000,"cash":19941000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AN2-502998","genericName":"AN2-502998","slug":"an2-502998","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AN2-502998","genericName":"AN2-502998","slug":"an2-502998","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-03-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOc3UxZFZIVHpFeFU4OW9ILUVNdnVDaWc2UnBWdU11SGRiSVhiTk84ZzFzREpRbVNqQWJLbmRYTGFfR3JNckx5ZkVFNDNiMHFpOGdIREprWEp0NGxobWlvT3lZUjVmUFFydVVYT2tKYWlTMHc3b1Vxdzdtd3lXSndsMFdUbXpld2hCMkVhekxxWVNVWnhIRDBzbFNQLUtKU0NHQ0tWa0pjVm5aeXZiYzFRQVpNcXFHNDJ2WHBhamFmWFBTYVU?oc=5","date":"2026-03-09","type":"pipeline","source":"Business Wire","summary":"AN2 Therapeutics Announces $40 Million Private Placement Financing - Business Wire","headline":"AN2 Therapeutics Announces $40 Million Private Placement Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPNDJmSENZbDV4c3hYWnF3Z252QlZFMG1hVlNBQjA2UjA3cTlUWkhfWjdXaUJid05Ydlh6Y3dHWEttRkkwQ2Z4VW1qX0hJWkFzY1VnUGhDaGZWVVhRME41aU55NlVmUm5RSVpmYnd4Sl9nd1JNaFAxQ09kcFo5cHh6ZGRnY0ZMU2Ryd09zcHZiOWdmTUM4SmttOEtBOW5mX0JBMEM2UlJFSGhHb0VDZEpEcDhR?oc=5","date":"2026-03-06","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Intraday Session - Firefly Neuroscience (NASDAQ:AIFF), AN2 Thera - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Intraday Session - Firefly Neuroscience (NASDAQ:AIFF), AN2 Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQWGMzOXRSX0RSRlJSM2RWbUlwZTlpLWRjbnR5dGplZTZNdFlxcG5lYXNVQnIzUFVibWpEM19oS25mZ1ZLWnpyWG1WbjA2OFh1czdXaDRlUXNYUWFpckltVF9BOGxSb1JibjVlWTFnX2VLTW5mTk5za0lKRmRFZDlPWnB0ZGI0U29uYlc1NVpYdFZKNFpuU0I4VjJMNkpjNG5tSnlJZEV1bWdTRGd0b1RxZHRtd2dUNzA?oc=5","date":"2026-03-06","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's After-Market Session - AN2 Therapeutics (NASDAQ:ANTX), Citius Ph - Benzinga","headline":"12 Health Care Stocks Moving In Friday's After-Market Session - AN2 Therapeutics (NASDAQ:ANTX), Citius Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTmF2b3l4UlJrV2pZcjVnYXRHdEYzZnRoQ2IybXpVYWR2RXJFSVF6Q1ZoTHd1aTZ6SDUwUlpKMHdvdGxpclhNZnBja2JkaWE2WVFkZ3F3bW4wdUtDaXFPNUFuTjdaeUQ5OW5VMGdmbUF4UE1RTER1WGJrZGVfeXpqRzlxSlMwc0t0Z3ViSExsM01IZlNmVzdrbWJGbTlIb2RIYzdGWnZ2MVA1cC1YU0g5SXllUnhma3Vm?oc=5","date":"2026-03-03","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's After-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNNVZOeEs5aF9ndG1DLWtVU1lrNjdjT2RWeTNsX3ZqSDc5cjZaUW9aRDhMV0gxSXVIakNPUDIzSXVRT3NFelBXcllZZ0E4emZwS2pRek84NUxaZkdDSVpOR1RNQTdBMndDMTFEbjQ3b3hqbjZrWjdpMW1razNmc3BZOGMzU3p1X0paR3JtcEx4b0NJc1ZucHFhemNXNzFGLXZzWUVXMnVsNWdhdGNtT0oxV0V6OUl3V2tUSld1N2JLRHBWRExWal94VERvZ0UwU3VSUmRwWUJfRnZwSk0yYXc?oc=5","date":"2026-02-17","type":"pipeline","source":"Business Wire","summary":"AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference - Business Wire","headline":"AN2 Therapeutics to Participate in Fireside Chat at Leerink Global Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-28","type":"pipeline","source":"simplywall.st","summary":"AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit - simplywall.st","headline":"AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE0zSzRxOHF6TE1pVG5aQkktSUVMTmsybTRNSjBDdGNUSnpnRUtCZnM3Y1JrdVl6QXExb1J6Z0kyX3VmWE1GNTRpblAyR0hEMTFVUk53?oc=5","date":"2025-05-02","type":"trial","source":"FirstWord Pharma","summary":"AN2 Therapeutics slides as MAC lung disease trial misses mark - FirstWord Pharma","headline":"AN2 Therapeutics slides as MAC lung disease trial misses mark","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WSHRTRHE3LVRlVzJ0UjJCY3pYYnh1TjZNbmFlVnpuc2R5ZFFjWUQwX1ptc2QxeW5KbDZPdnVQLTJtZk5sck9MZG01NFRfeFZXVkhB?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"ANTX Stock Price, News & Analysis - Stock Titan","headline":"ANTX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQNVNSY3cxSlVVbUY3WWtTd3VmVVFMX1FSSzRybjhBNUtNT3pMeTlERjJRbk82aUhxWmo2UUh2UDFsb2hqV2ZlbmdETDlIMWZUenp4Z21KNmlPZl9BVUV6YzkyN3Z0UWg5LXVCbzZJRzI2NmNGX2ZXUjQ5NGFzQTFQYkV6U0c?oc=5","date":"2024-08-19","type":"pipeline","source":"Yahoo Finance","summary":"AN2 Therapeutics (ANTX) Plunges 66% in a Month: Here's Why - Yahoo Finance","headline":"AN2 Therapeutics (ANTX) Plunges 66% in a Month: Here's Why","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdmtkTkMzSkFjbkFyZFloc0VVX2JDaEFhYkNySnprVGxRY2lhX2xpZVplaEJweXdzaXNBMXhDbXVOaHJBcmE0aG4zMFJiMGFzTERCMnBhMEFMbWJ2VVFEYzRzMk40NndUNzE2UXlCdHBzWUJHa2pLdERuNEN1bXMwQi1UU3Uweld1clFfeTBkNXUyd2JVUkZqRkVTQnFKTGk2ZHdUUW1VLTIzTmViTjVtUG1hWVVJb1Ezb1pEemloNmtKcVdhSkwxRW5BUlQwZ3hIY2ZJUm1IdnZ3eWxrSGstQzg5UldnZms?oc=5","date":"2024-08-12","type":"trial","source":"respiratory-therapy.com","summary":"AN2 Therapeutics Stops Phase 2/3 Epetraborole Trial for MAC Lung Disease - respiratory-therapy.com","headline":"AN2 Therapeutics Stops Phase 2/3 Epetraborole Trial for MAC Lung Disease - respiratory","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE04Y2x2SlpnbnVjZWl1YW02U2N4b09zYlF6Q2xGUWRJblNvR1FvNzNyUE1MQk13alpSbi02SGxVTkVZMk13aFdRempob0I1aVBIdDhNMWQ5Q0lQU0lk?oc=5","date":"2024-04-28","type":"pipeline","source":"TradingView","summary":"ANTX Stock Price and Chart — NASDAQ:ANTX - TradingView","headline":"ANTX Stock Price and Chart — NASDAQ:ANTX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSkFVX3lxTFB4RkVQSnpxVDNCSl9DN1hHTGk4WjR6MHM1ZGNLcTJGQU4yYkktc1c5QXoxb0dEa0lBTGhBUkx1WlZVNVpja3pMQW9n?oc=5","date":"2024-01-31","type":"pipeline","source":"eToro","summary":"AN2 Therapeutics Inc (ANTX) Stock Price, News & Analyst Forecast - eToro","headline":"AN2 Therapeutics Inc (ANTX) Stock Price, News & Analyst Forecast","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":24769000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-35174000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":19941000,"cashHistory":[],"totalAssets":61950000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}